Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × enzalutamide × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

pembrolizumab 9 Gemcitabine 7 Carboplatin 7 Cisplatin 6 Pemetrexed 4 Paclitaxel 4 durvalumab 3 Ipilimumab 3 Cyclophosphamide 3 talquetamab 2 niraparib 2 lenvatinib 2 inavolisib 2 entrectinib 2 atezolizumab 2 X-Rays 2 Vincristine 2 Specimen Handling 2 Saline Solution 2 Rituximab 2 Prednisone 2 Nivolumab 2 Midazolam 2 Leucovorin 2 Etoposide 2 Brentuximab Vedotin 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 zanubrutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03395197 2026-03-12

TALAPRO-2

Pfizer

Phase 3 Active not recruiting

1,054 enrolled 21 charts 1 FDA

mCRPC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡